Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

PURPOSE: The therapeutic efficacy of targeted therapy for adenosquamous carcinoma (ASC) of the lung remains unclear and the role of epidermal growth factor receptor (EGFR) testing in patients with ASC also remains controversial. We aimed to analyze the efficacy of EGFR tyrosine kinase inhibitors (EG...

Full description

Saved in:
Bibliographic Details
Published in:Onco Targets Ther
Main Authors: Fan, Liwen, Yang, Haitang, Yao, Feng, Zhao, Yang, Gu, Haiyong, Han, Ke, Zhao, Heng
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2017
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5229167/
https://ncbi.nlm.nih.gov/pubmed/28123305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114451
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items